The first newsletter of ProCAncer-I has been published!

An AI Platform integrating imaging data and models, supporting precision care through prostate cancer’s continuum: In Europe, prostate cancer (PC) is the second most frequent type of cancer in men and the third most lethal. Current clinical practices lead to overdiagnosis and overtreatment, necessitating more effective tools for discriminating between aggressive and non-aggressive disease. The EU-funded ProCAncer-I project proposes to develop advanced artificial intelligence models to address unmet clinical needs: diagnosis, metastases detection and prediction of response to treatment. To achieve this, partners will generate a large interoperable repository of health images, and a scalable high-performance computing platform hosting the largest collection of PC Magnetic Resonance Images used for developing robust PC AI models. To ensure the rapid clinical implementation of the models developed, the project’s partners will robustly monitor performance, accuracy and reproducibility. 

Welcome by Coordinating Team

We are very glad to lead a very ambitious and health-driven project that could end to alleviating and helping thousands of men to tackle prostate cancer in a more personalized way supporting a better quality of life

The Coordinating Team

Manolis Tsiknakis

Prof. Manolis Tsiknakis
(Coordinator)

Dr. Nickolaos Papanickolaou
(Scientific Manager)

Prof. Kostas Marias
(Technical Manager)

Prof. Danielle Regge
(Clinical Manager)

Project Information

Months (Duration)

Euros (Total Budget )

Grant Agreement Nr.

Funded

This project has received funding from the European Union’s Horizon 2020 research and innovation programme

|

Topic

DT-TDS-05-2020:
AI for Health Imaging

Highlights

Ελπίδα από Έλληνες επιστήμονες για τον καρκίνο του προστάτη

Ελπίδα από Έλληνες επιστήμονες για τον καρκίνο του προστάτη

Ελπίδα για καλύτερη διάγνωση, θεραπεία και βελτιωμένη ποιότητα ζωής στους ασθενείς που πάσχουν από καρκίνο του προστάτη, δίνει το νέο πανευρωπαϊκό πρόγραμμα ProCAncer-I στο οποίο συμμετέχει και η Ελλάδα καθώς συντονιστής φορέας είναι το Ινστιτούτο Τεχνολογίας και Έρευνας (ΙΤΕ) στην Κρήτη.

Fighting prostate cancer with over 1.5 million MRI images

Fighting prostate cancer with over 1.5 million MRI images

Men die about five years earlier than women across the world. As initiatives to boost awareness of men’s health unfolded in November, an international project is bringing the forefront of AI research to tackle prostate cancer (PC), the second most frequent type of cancer in men and the third most lethal in Europe.

Novartis prostate cancer drug receives U.S. FDA breakthrough designation https://www.reuters.com/business/healthcare-pharmaceuticals/novartis-prostate-cancer-drug-receives-us-fda-breakthrough-designation-2021-06-16/ #prostatecancer

Dr Nickolas Papanikolaou is presenting our project ProCAncer-I at the Health IT Conference on Tuesday 15/6/21. He will talk about the creation of a platfrom containing datasets and AI models for monitoring patients with prostate cancer
@FORTH_ITE https://healthdaily.gr/2021/06/12/tin-triti-anoigei-tin-avlaia-tou-to-4o-health-it-conference/

See the first @ProCAncer_I newsletter. Get to know the ProCAncer-I project, its vision, its anonymization strategy, the legal & ethical issues that were dealt & the MRI based AI tools that will improve the management of patients with prostate cancer. https://tinyurl.com/pci-news01

🤖 #DigitalEU2030
⏰ 1 & 2 June
🖥️ Virtual event

Two days fully dedicated to new #digital technologies, opportunities & next steps to make this Europe's Digital Decade!

Join the debate 👉 http://bit.ly/DigitalEU2030

Load More...

Stay in touch!